151 related articles for article (PubMed ID: 3150847)
1. [Cell culture--its application in the study of hormone and endometrial carcinoma and feed-back to clinical medicine].
Kuramoto H
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Aug; 40(8):1050-5. PubMed ID: 3150847
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of action of endocrine therapy of endometrial carcinoma].
Kuramoto H; Hata H; Kato Y; Hata K; Hamano M; Anzai Y; Watanabe J; Holinka CF; Gurpide E
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1851-7. PubMed ID: 2730078
[TBL] [Abstract][Full Text] [Related]
3. [Responsiveness and mechanisms of action of steroid hormones in human endometrial adenocarcinoma cells].
Hata H; Hata K; Hamano M; Shimoda T; Kuramoto H
Hum Cell; 1989 Sep; 2(3):265-71. PubMed ID: 2519214
[TBL] [Abstract][Full Text] [Related]
4. [Growth regulation of sex steroid hormone in endometrial carcinoma transplanted into nude mice].
Kato Y; Morisawa T; Kuramoto H
Hum Cell; 1991 Jun; 4(2):165-70. PubMed ID: 1835653
[TBL] [Abstract][Full Text] [Related]
5. Effects of sex steroid hormones on the human endometrial carcinoma transplanted endometrial carcinoma transplanted into nude mice. Estrogen priming aimed at the enhancement of tumor tissue-sensitivity to progesterone.
Tohtake T
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):2007-16. PubMed ID: 6663132
[TBL] [Abstract][Full Text] [Related]
6. [Effects of female sex steroid hormones on human endometrial adenocarcinoma transplanted into nude mice].
Miyawaki Y
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2607-16. PubMed ID: 2614195
[TBL] [Abstract][Full Text] [Related]
7. [Endocrinological contribution for invasion and metastasis in gynecological cancers].
Fujimoto J
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):633-43. PubMed ID: 8808831
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
[TBL] [Abstract][Full Text] [Related]
9. [Growth inhibition by progestins in human endometrial cancer cells with progesterone receptors].
Tanizawa O; Terakawa N
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):917-23. PubMed ID: 3389835
[TBL] [Abstract][Full Text] [Related]
10. Regulation of estrogen receptor levels in endometrial cancer cells.
Gurpide E; Blumenthal R; Fleming H
Prog Clin Biol Res; 1984; 142():145-65. PubMed ID: 6709655
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice.
Satyaswaroop PG; Zaino RJ; Mortel R
Cancer Res; 1984 Sep; 44(9):4006-10. PubMed ID: 6744316
[TBL] [Abstract][Full Text] [Related]
12. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
Reddel RR; Alexander IE; Koga M; Shine J; Sutherland RL
Cancer Res; 1988 Aug; 48(15):4340-7. PubMed ID: 3390830
[TBL] [Abstract][Full Text] [Related]
13. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
14. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
Kumar NS; Richer J; Owen G; Litman E; Horwitz KB; Leslie KK
Cancer Res; 1998 May; 58(9):1860-5. PubMed ID: 9581825
[TBL] [Abstract][Full Text] [Related]
15. The influence of hormones on CD44 expression in endometrial and breast carcinomas.
Durst B; Sorg RV; Röder G; Betz B; Beckmann MW; Niederacher D; Bender HG; Dall P
Oncol Rep; 2001; 8(5):987-93. PubMed ID: 11496303
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor activation in relation to previous estrogen treatment in carcinoma corporis uteri heterotransplanted into nude mice.
Horvath G; Fernö M; Cameron R; Ranstam J
In Vivo; 1989; 3(2):93-7. PubMed ID: 2519844
[TBL] [Abstract][Full Text] [Related]
17. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
[TBL] [Abstract][Full Text] [Related]
18. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice.
Friedl A; Gottardis MM; Pink J; Buchler DA; Jordan VC
Cancer Res; 1989 Sep; 49(17):4758-64. PubMed ID: 2758409
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition by progestins in a human endometrial cancer cell line with estrogen-independent progesterone receptors.
Terakawa N; Hayashida M; Shimizu I; Ikegami H; Wakimoto H; Aono T; Tanizawa O; Matsumoto K; Nishida M
Cancer Res; 1987 Apr; 47(7):1918-23. PubMed ID: 3815380
[TBL] [Abstract][Full Text] [Related]
20. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
